Management of Residual or Recurrent Disease Following Thermal Ablation of Renal Cortical Tumors [0.03%]
射频消融治疗肾皮质肿瘤术后的残存病灶或复发病灶的处理措施
Justin Loloi,W Bruce Shingleton,Stephen Y Nakada et al.
Justin Loloi et al.
Management of residual or recurrent disease following thermal ablation of renal cortical tumors includes surveillance, repeat ablation, or surgical extirpation. We present a multicenter experience with regard to the management of this clini...
Ulka Vaishampayan
Ulka Vaishampayan
Spontaneous Retroperitoneal Hemorrhage in a Patient with Acquired Cystic Kidney Disease [0.03%]
获得性肾囊肿疾病患者的自发性腹膜后出血
Ahmed Kotb,Asmaa Ismail,Hazem Elmansy et al.
Ahmed Kotb et al.
Spontaneous retroperitoneal hemorrhage (SRH) is a rare emergency. It is usually encountered in patients on hemodialysis and is associated with high rate of morbidity and mortality. This is a case from the emergency department. The patient h...
Computed Tomography Imaging Characteristics of Histologically Confirmed Papillary Renal Cell Carcinoma-Implications for Ancillary Imaging [0.03%]
组织学证实的乳头状肾细胞癌的CT影像特征-对辅助影像的影响
Jeffrey B Walker,Justin Loloi,Alexander Birk et al.
Jeffrey B Walker et al.
Low-attenuation renal lesions on non-contrast computed tomography (CT) are often considered to be benign cysts without need for further imaging. However, the papillary subtype of renal cell carcinoma (RCC) may have similar radiographic char...
Ayun Cassell,Mohamed Jalloh,Bashir Yunusa et al.
Ayun Cassell et al.
There is a global variation in the incidence of renal masses with the developed nations having a greater incidence. About 80-90% of renal malignancies are renal cell carcinomas (RCC) which account for 2-4% of all cancers. In Africa and the ...
Predictors of Cytoreductive Nephrectomy for Metastatic Kidney Cancer in SEER and Metropolitan Detroit Databases [0.03%]
美国监测、流行病学和最终结果（SEER）数据库和底特律地区数据库肾癌转移患者辅助性肾切除术的预测因素分析
Ulka Vaishampayan,Julie George,Fawn Vigneau
Ulka Vaishampayan
Patients without cytoreductive nephrectomy (CN) are inadequately represented in metastatic renal cell carcinoma (RCC) clinical trials. The characteristics that impact the decision of CN were explored in the SEER database. Data on primary, r...
Trifecta Outcomes in Open, Laparoscopy or Robotic Partial Nephrectomy: Does the Surgical Approach Matter? [0.03%]
开放手术、腹腔镜和机器人辅助部分肾切除术的 trifecta效果：手术入路方式重要吗？
Ketan Mehra,Ramanitharan Manikandan,Lalgudi Narayanan Dorairajan et al.
Ketan Mehra et al.
This retrospective study evaluated perioperative outcomes of open partial nephrectomy (OPN), laparoscopic partial nephrectomy (LPN), and robot-assisted partial nephrectomy (RAPN) and identified predictive factors of Trifecta achievement for...
Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma? [0.03%]
移除肾细胞癌转移性肿瘤的肾脏还有必要吗？
Alex Renner,Suraj Samtani,Arnaldo Marín et al.
Alex Renner et al.
Cytoreductive nephrectomy has been an integral part of management in metastatic renal cell carcinoma for patients with good performance status, based on the benefit shown by prospective trials in the interferon era and retrospective trials ...
Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and Paraganglioma [0.03%]
嗜铬细胞瘤和副神经节瘤的临床综合征及基因筛查策略
Peihua Liu,Minghao Li,Xiao Guan et al.
Peihua Liu et al.
Pheochromocytomas (PCCs) are rare neuroendocrine tumors that originate from chromaffin cells of the adrenal medulla, and paragangliomas (PGLs) are extra-adrenal pheochromocytomas. These can be mainly found in clinical syndromes including mu...
Implications of Programmed Death Ligand-1 Positivity in Non-Clear Cell Renal Cell Carcinoma [0.03%]
非透明细胞肾细胞癌中程序性死亡配体-1阳性的影响
Juan Chipollini,Mounsif Azizi,Charles C Peyton et al.
Juan Chipollini et al.
The purpose of this study was to assess the prognostic value of programmed death ligand-1 (PD-L1) positivity in a non-clear cell renal cell carcinoma (non-ccRCC) cohort. PD-L1 expression was evaluated by immunohistochemistry (IHC) using for...